ADMA Biologics(ADMA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ADMA ADMA Biologics

Pre-Mkt 12-23 05:04:28 EST

19.88

+0.30

+1.53%

High19.94	Low19.53	Vol1.46M
Open19.58	D1 Closing19.58	Amplitude2.09%
Mkt Cap4.73B	Tradable Cap4.65B	Total Shares238.00M
T/O29.03M	T/O Rate0.63%	Tradable Shares233.86M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ADMA","market":"US","secType":"STK","nameCN":"ADMA Biologics","latestPrice":19.88,"timestamp":1766437200000,"preClose":19.58,"halted":0,"volume":1463888,"delay":0,"floatShares":233862209,"shares":237997765,"eps":0.855978,"marketStatus":"Pre-Mkt","change":0.3,"latestTime":"12-23 05:04:28 EST","open":19.58,"high":19.94,"low":19.53,"amount":29030317.547472,"amplitude":0.02094,"askPrice":20.49,"askSize":139,"bidPrice":19.81,"bidSize":139,"shortable":3,"etf":0,"ttmEps":0.855978,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1766500200000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":19.88,"postHourTrading":{"tag":"盘后","latestPrice":19.88,"preClose":19.88,"latestTime":"19:58 EST","volume":55550,"amount":1104281.18,"timestamp":1766451483664},"volumeRatio":0.4987056508268919,"impliedVol":0.5593,"impliedVolPercentile":0.3735},"requestUrl":"/m/hq/s/ADMA","defaultTab":"news","newsList":[{"id":"2592952519","title":"ADMA Biologics CEO Adam S. Grossman Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2592952519","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592952519?lang=en_us&edition=fundamental","pubTime":"2025-12-17 10:00","pubTimestamp":1765936857,"startTime":"0","endTime":"0","summary":"Adam S. Grossman, President and CEO of ADMA Biologics Inc., reported a disposal of common shares of ADMA Biologics Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ADMA Biologics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 16, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nNDLb0frdf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"ADMA Biologics CEO Adam S. Grossman Reports Disposal of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ADMA"],"gpt_icon":0},{"id":"2586261741","title":"ADMA Biologics (ADMA): Assessing Valuation as Short Interest Declines and Market Sentiment Improves","url":"https://stock-news.laohu8.com/highlight/detail?id=2586261741","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586261741?lang=en_us&edition=fundamental","pubTime":"2025-11-27 00:14","pubTimestamp":1764173662,"startTime":"0","endTime":"0","summary":"ADMA Biologics (ADMA) has seen its short interest drop by nearly 5% since the last report, now sitting at just under 9%. This is noticeably below the biotech's average peer short interest, which hovers above 14%.\nSee our latest analysis for ADMA Biologics.\nADMA Biologics has demonstrated impressive momentum lately, with its share price jumping 22.4% in the past week and 26.6% over the past month. While the total shareholder return over the past year is still in negative territory, the...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-adma/adma-biologics/news/adma-biologics-adma-assessing-valuation-as-short-interest-de","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-adma/adma-biologics/news/adma-biologics-adma-assessing-valuation-as-short-interest-de","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","ADMA"],"gpt_icon":0},{"id":"2585030466","title":"High Growth Tech Stocks In The US For November 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2585030466","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585030466?lang=en_us&edition=fundamental","pubTime":"2025-11-24 19:08","pubTimestamp":1763982486,"startTime":"0","endTime":"0","summary":"The U.S. stock market has recently experienced significant volatility, with major indices like the Nasdaq and S&P 500 posting substantial losses despite strong earnings reports from companies like Nvidia. This turbulent environment highlights the importance of identifying high-growth tech stocks that can withstand market fluctuations and capitalize on emerging trends, making them potentially attractive options for investors seeking growth opportunities in an unpredictable landscape.","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/8041000-choice2-main-header/1585186556238","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/8041000-choice2-main-header/1585186556238"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/software/nasdaq-clbt/cellebrite-di/news/high-growth-tech-stocks-in-the-us-for-november-2025","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/software/nasdaq-clbt/cellebrite-di/news/high-growth-tech-stocks-in-the-us-for-november-2025","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","CLBT","CARG","ADMA","BK4613","BK4077","BK4023"],"gpt_icon":0},{"id":"2585120827","title":"ADMA Biologics CEO Adam S. Grossman Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2585120827","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585120827?lang=en_us&edition=fundamental","pubTime":"2025-11-22 10:01","pubTimestamp":1763776876,"startTime":"0","endTime":"0","summary":"Adam S. Grossman, President and CEO of ADMA Biologics Inc., has reported a disposal of common shares of ADMA Biologics Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ADMA Biologics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 21, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251122:nNDL5Bjm6T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"ADMA Biologics CEO Adam S. Grossman Reports Disposal of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADMA","BK4139"],"gpt_icon":0},{"id":"2581092641","title":"ADMA Biologics (ADMA) Receives a New Rating from Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2581092641","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581092641?lang=en_us&edition=fundamental","pubTime":"2025-11-06 22:57","pubTimestamp":1762441040,"startTime":"0","endTime":"0","summary":"ADMA Biologics received a Buy rating and a $30.00 price target from Cantor Fitzgerald analyst Kristen Kluska yesterday. According to TipRanks, Klus...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/adma-biologics-adma-receives-a-new-rating-from-cantor-fitzgerald-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/adma-biologics-adma-receives-a-new-rating-from-cantor-fitzgerald-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ADMA"],"gpt_icon":0},{"id":"2581826031","title":"ADMA Biologics Reports Strong Q3 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2581826031","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581826031?lang=en_us&edition=fundamental","pubTime":"2025-11-06 12:58","pubTimestamp":1762405122,"startTime":"0","endTime":"0","summary":"ADMA Biologics Inc ( ($ADMA) ) has released its Q3 earnings. Here is a breakdown of the information ADMA Biologics Inc presented to its investors. ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/adma-biologics-reports-strong-q3-2025-financial-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/adma-biologics-reports-strong-q3-2025-financial-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ADMA"],"gpt_icon":0},{"id":"1126909388","title":"Stock Track | ADMA Biologics Plunges 5.72% After-Hours Despite Strong Q3 Results and Raised Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=1126909388","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126909388?lang=en_us&edition=fundamental","pubTime":"2025-11-06 05:55","pubTimestamp":1762379705,"startTime":"0","endTime":"0","summary":"ADMA Biologics (NASDAQ:ADMA) shares tumbled 5.72% in after-hours trading on Wednesday, despite reporting better-than-expected third-quarter results and raising its full-year guidance. The sharp...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["ADMA"],"gpt_icon":0},{"id":"2581583701","title":"BRIEF-ADMA Biologics Q3 Revenue USD 134.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2581583701","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581583701?lang=en_us&edition=fundamental","pubTime":"2025-11-06 05:06","pubTimestamp":1762376761,"startTime":"0","endTime":"0","summary":"BRIEF-ADMA Biologics Q3 Revenue USD 134.2 Million\n\n\nNov 05 (Reuters) - ADMA Biologics Q3 net income USD 36.4 million.\n\nQ3 adjusted EBITDA USD 58.7 million\nQ3 gross profit USD 75.6 million\nQ3 adjusted net income USD 38.9 million\noutlook FY revenue USD 510 million","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nPLX27CE15:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ADMA"],"gpt_icon":0},{"id":"2581083994","title":"ADMA Biologics Inc Outlook  2026 Total Revenue: Raised to at Least $630 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2581083994","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581083994?lang=en_us&edition=fundamental","pubTime":"2025-11-06 05:05","pubTimestamp":1762376716,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nPLX27CE15:7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ADMA","BK4139"],"gpt_icon":0},{"id":"2581440701","title":"ADMA Biologics Announces Third Quarter 2025 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2581440701","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581440701?lang=en_us&edition=fundamental","pubTime":"2025-11-06 05:05","pubTimestamp":1762376700,"startTime":"0","endTime":"0","summary":"3Q 2025 Total Revenue of $134.2 Million, a 12% YoY Increase 3Q 2025 GAAP Net Income of $36.4 Million, a 1% YoY Increase  3Q 2025 Adjusted EBITDA(1) of $58.7 Million, a 29% YoY Increase  3Q 2025 Adjust","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/05/3181938/33130/en/ADMA-Biologics-Announces-Third-Quarter-2025-Financial-Results-and-Provides-Business-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMS","LU1878469433.USD","PI","BK4141","IG","BK4196","BK4139","ADMA"],"gpt_icon":0},{"id":"2581062477","title":"Adma Biologics options imply 14.3% move in share price post-earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2581062477","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581062477?lang=en_us&edition=fundamental","pubTime":"2025-11-06 04:35","pubTimestamp":1762374932,"startTime":"0","endTime":"0","summary":"Pre-earnings options volume in Adma Biologics (ADMA) is 9.4x normal with calls leading puts 8:3. Implied volatility suggests the market is anticipa...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/adma-biologics-options-imply-14-3-move-in-share-price-post-earnings-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/adma-biologics-options-imply-14-3-move-in-share-price-post-earnings-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ADMA"],"gpt_icon":0},{"id":"1120319420","title":"Stock Track | ADMA Biologics Soars 5% Ahead of Expected Strong Q3 Earnings Report","url":"https://stock-news.laohu8.com/highlight/detail?id=1120319420","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120319420?lang=en_us&edition=fundamental","pubTime":"2025-11-06 02:19","pubTimestamp":1762366788,"startTime":"0","endTime":"0","summary":"Shares of ADMA Biologics (NASDAQ: ADMA) surged 5.06% higher on Wednesday, as investors eagerly anticipate the company's third-quarter earnings report scheduled for release after the market close. The...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["ADMA"],"gpt_icon":0},{"id":"1174886486","title":"Stock Track | ADMA Biologics Soars 5.06% Ahead of Expected Positive Q3 Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=1174886486","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174886486?lang=en_us&edition=fundamental","pubTime":"2025-11-06 02:19","pubTimestamp":1762366763,"startTime":"0","endTime":"0","summary":"ADMA Biologics (NASDAQ: ADMA) saw its stock price surge 5.06% in Wednesday's trading session, as investors showed optimism ahead of the company's anticipated third-quarter earnings report. The...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["ADMA"],"gpt_icon":0},{"id":"2580951224","title":"ADMA Biologics Inc  expected to post earnings of 15 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2580951224","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580951224?lang=en_us&edition=fundamental","pubTime":"2025-11-04 07:04","pubTimestamp":1762211045,"startTime":"0","endTime":"0","summary":"ADMA Biologics Inc  expected to post earnings of15cents a share - Earnings Preview ADMA Biologics Inc ADMA.OQ ADMA.O is expected to  show a rise in quarterly revenue when it reports  results on Novemb","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nL8N3WF2LV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADMA","BK4139"],"gpt_icon":0},{"id":"2579974696","title":"ADMA Biologics Inc. to Report Third Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2579974696","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579974696?lang=en_us&edition=fundamental","pubTime":"2025-10-29 19:00","pubTimestamp":1761735613,"startTime":"0","endTime":"0","summary":"ADMA Biologics Inc. will report third quarter 2025 financial results on November 5, 2025, after the U.S. financial markets close. A live conference call and audio webcast to discuss the results and company updates will be held on November 5, 2025, at 4:30 p.m. ET. The results will be released under \"Events & Webcasts\" in the investor section of the Company's website at Events & Webcasts. Participants must register for the call to receive dial-in numbers and a unique PIN. An archived replay will also be available at the same URL.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ADMA Biologics Inc. published the original content used to generate this news brief via GlobeNewswire  on October 29, 2025, and is solely responsible for the infor","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251029:nNDL44Hcry:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","IE00BGHQF748.EUR","IE00B64PRP62.GBP","LU0314104364.USD","NDAQ","BK4112","IE00B3QW5Z07.USD","LU2095319765.USD","LU2210149790.SGD","IE00BKPKM429.USD","BK4139","ADMA","BK4585","BK4588"],"gpt_icon":0},{"id":"2578524091","title":"ADMA Biologics CEO Adam S. Grossman Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2578524091","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578524091?lang=en_us&edition=fundamental","pubTime":"2025-10-25 09:06","pubTimestamp":1761354377,"startTime":"0","endTime":"0","summary":"Adam S. Grossman, President and CEO of ADMA Biologics Inc., reported a disposal of common shares of ADMA Biologics Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ADMA Biologics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 24, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251025:nNDL8nC4Vp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ADMA"],"gpt_icon":0},{"id":"2575752747","title":"Assessing ADMA Biologics’s Valuation Following Bold Multi-Year Growth Targets and Manufacturing Upgrades","url":"https://stock-news.laohu8.com/highlight/detail?id=2575752747","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575752747?lang=en_us&edition=fundamental","pubTime":"2025-10-16 03:24","pubTimestamp":1760556281,"startTime":"0","endTime":"0","summary":"ADMA Biologics (ADMA) just laid out some big plans, unveiling multi-year revenue goals that stretch through 2026 and beyond. Management’s updated guidance highlights expansions at its Boca Raton facility, along with a new process expected to boost yields.\nSee our latest analysis for ADMA Biologics.\nAfter unveiling its ambitious multi-year revenue targets and operational upgrades, ADMA Biologics has caught fresh investor attention, reflected in last week's 6.9% share price gain and a rebound...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-adma/adma-biologics/news/assessing-adma-biologicss-valuation-following-bold-multi-yea","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-adma/adma-biologics/news/assessing-adma-biologicss-valuation-following-bold-multi-yea","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ADMA"],"gpt_icon":0},{"id":"2570044190","title":"Exploring High Growth Tech Stocks in the US Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2570044190","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570044190?lang=en_us&edition=fundamental","pubTime":"2025-09-26 01:08","pubTimestamp":1758820093,"startTime":"0","endTime":"0","summary":"As the U.S. stock market experiences a pullback with major indexes like the Nasdaq and S&P 500 declining ahead of crucial inflation data, investors are closely monitoring economic indicators such as GDP growth and jobless claims that impact small-cap companies. In this context, identifying high-growth tech stocks requires a focus on innovation potential and resilience amidst fluctuating market conditions.","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/4313000-choice1-main-header/1585186956346","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/4313000-choice1-main-header/1585186956346"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/media/nasdaq-roku/roku/news/exploring-high-growth-tech-stocks-in-the-us-market-18","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/media/nasdaq-roku/roku/news/exploring-high-growth-tech-stocks-in-the-us-market-18","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4548","BK4023","BK4507","BK4588","ADMA","BK4139","BK4524","BK4532","LU1861558580.USD","BK4585","LU1861559042.SGD","DSP","ROKU","BK4108"],"gpt_icon":0},{"id":"2559944172","title":"ADMA Biologics Inc. President and CEO Adam S. Grossman Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2559944172","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559944172?lang=en_us&edition=fundamental","pubTime":"2025-08-16 09:00","pubTimestamp":1755306054,"startTime":"0","endTime":"0","summary":"Adam S. Grossman, President and CEO of ADMA Biologics Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ADMA Biologics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 15, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250816:nNDL3dg5mP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADMA","BK4139"],"gpt_icon":0},{"id":"1123208590","title":"Stock Track | ADMA Biologics Plummets 17.72% as Q2 Sales Miss Sparks Investor Concerns","url":"https://stock-news.laohu8.com/highlight/detail?id=1123208590","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123208590?lang=en_us&edition=fundamental","pubTime":"2025-08-07 22:06","pubTimestamp":1754575595,"startTime":"0","endTime":"0","summary":"ADMA Biologics (NASDAQ:ADMA) saw its stock price plummet by 17.72% in pre-market trading on Thursday, following a disappointing after-hours session on Wednesday. The sharp decline comes in the wake...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["ADMA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.admabiologics.com","stockEarnings":[{"period":"1week","weight":0.0076},{"period":"1month","weight":0.1572},{"period":"3month","weight":0.2441},{"period":"6month","weight":0.1295},{"period":"1year","weight":0.1425},{"period":"ytd","weight":0.1592}],"compareEarnings":[{"period":"1week","weight":0.006},{"period":"1month","weight":0.0391},{"period":"3month","weight":0.0326},{"period":"6month","weight":0.128},{"period":"1year","weight":0.1585},{"period":"ytd","weight":0.1685}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. The company also develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, it operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.","yearOnYearQuotes":[{"month":1,"riseRate":0.454545,"avgChangeRate":0.027611},{"month":2,"riseRate":0.545455,"avgChangeRate":-0.01132},{"month":3,"riseRate":0.636364,"avgChangeRate":0.108134},{"month":4,"riseRate":0.636364,"avgChangeRate":0.024806},{"month":5,"riseRate":0.636364,"avgChangeRate":0.053968},{"month":6,"riseRate":0.181818,"avgChangeRate":-0.056361},{"month":7,"riseRate":0.727273,"avgChangeRate":0.105206},{"month":8,"riseRate":0.272727,"avgChangeRate":0.003287},{"month":9,"riseRate":0.181818,"avgChangeRate":-0.032166},{"month":10,"riseRate":0.454545,"avgChangeRate":-0.041559},{"month":11,"riseRate":0.636364,"avgChangeRate":0.093715},{"month":12,"riseRate":0.416667,"avgChangeRate":-0.053417}],"exchange":"NASDAQ","name":"ADMA Biologics","nameEN":"ADMA Biologics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ADMA Biologics(ADMA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest ADMA Biologics(ADMA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"ADMA Biologics,ADMA,ADMA Biologics股票,ADMA Biologics股票老虎,ADMA Biologics股票老虎国际,ADMA Biologics行情,ADMA Biologics股票行情,ADMA Biologics股价,ADMA Biologics股市,ADMA Biologics股票价格,ADMA Biologics股票交易,ADMA Biologics股票购买,ADMA Biologics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ADMA Biologics(ADMA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest ADMA Biologics(ADMA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction